
Project Sentinel provides early tumor surveillance for post-operative prostate cancer patients with an implantable biosensor. The sensor is placed under the skin and uses optical readout with a portable probe, with signals analyzed by machine learning to infer disease status. It is a minimally invasive, biocompatible implant intended for regular clinical monitoring. Key technologies include implantable biosensor hardware, optical readout, portable reader, and ML analytics, positioned as a medical device for hospitals and clinics. The system targets the healthcare market for post-surgical cancer surveillance and scalable adoption in clinical workflows.

Project Sentinel provides early tumor surveillance for post-operative prostate cancer patients with an implantable biosensor. The sensor is placed under the skin and uses optical readout with a portable probe, with signals analyzed by machine learning to infer disease status. It is a minimally invasive, biocompatible implant intended for regular clinical monitoring. Key technologies include implantable biosensor hardware, optical readout, portable reader, and ML analytics, positioned as a medical device for hospitals and clinics. The system targets the healthcare market for post-surgical cancer surveillance and scalable adoption in clinical workflows.